Lv51
950 积分 2020-11-11 加入
HLX11: A Pertuzumab Biosimilar
3小时前
已关闭
An Improved Impact Ratio for Identifying Critical Process Parameters in Pharmaceutical Manufacturing Processes
25天前
已完结
Proactive Approaches to cGMP Compliance: Insights and Key Takeaways from USFDA Warning Letters to Pharmaceutical Industries Between 2019 and 2024
2个月前
已完结
A Retrospective Analysis of FDA Warning Letters Issued For Biologics From 2010 To 2025
2个月前
已完结
Establishment of Limit of In Vitro Cell Age (LIVCA) for Biologics Manufacturing Process
2个月前
已完结
Analysis of virus clearance for biotechnology manufacturing processes from early to late phase development
5个月前
已完结
Ultra scale‐down prediction using microwell technology of the industrial scale clarification characteristics by centrifugation of mammalian cell broths
5个月前
已完结
Analysis of virus clearance for biotechnology manufacturing processes from early to late phase development
5个月前
已完结
Glycan Profiles of FDA-Approved Therapeutic Antibodies: Insights from Regulatory Submissions
8个月前
已完结
Methods for Estimating the Probability of Clonality in Cell Line Development
9个月前
已完结
皖公网安备34019202002308
